US 8614304
Immunogenic peptides and methods of use for treating and preventing cancer
granted A61KA61K39/0011A61K40/11
Quick answer
US patent 8614304 (Immunogenic peptides and methods of use for treating and preventing cancer) held by The United States of America, as represented by the Secretary, Department of Health and Human Serives expires Mon Dec 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Serives
- Grant date
- Tue Dec 24 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K39/0011, A61K40/11, A61K40/42, A61P